146 related articles for article (PubMed ID: 36217263)
1. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
Li Z; Cai J; Zhao Y; Cai J; Zhao X
J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
[TBL] [Abstract][Full Text] [Related]
2. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
3. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
4. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
5. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
Yue YS; Sun ZH; Cui Q; Jiang GZ
Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Obstacles in Pathological Diagnosis of Pulmonary Nodules through Circulating Tumor Cell Enrichment.
Yin W; Zhu J; Ma B; Jiang G; Zhu Y; He W; Yang Y; Zhang Z
Small; 2020 Jun; 16(25):e2001695. PubMed ID: 32452626
[TBL] [Abstract][Full Text] [Related]
9. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
Yan S; Guo W; Liu Y; Li K; Wang W
Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
11. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
[TBL] [Abstract][Full Text] [Related]
12. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
[TBL] [Abstract][Full Text] [Related]
13. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
14. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
Ma M; Xu S; Han B; He H; Ma X; Chen C
Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
[TBL] [Abstract][Full Text] [Related]
15. Value of peripheral blood circulating tumor cell detection in the diagnosis of thoracic diseases and the prediction of severity.
Qi C; Xiong XZ
Clin Exp Med; 2023 Oct; 23(6):2331-2339. PubMed ID: 36929453
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
17. Preoperative diagnosis of solitary pulmonary nodules with a novel hematological index model based on circulating tumor cells.
Zhou Q; He Q; Peng L; Huang Y; Li K; Liu K; Li D; Zhao J; Sun K; Li A; He W
Front Oncol; 2023; 13():1150539. PubMed ID: 37207165
[TBL] [Abstract][Full Text] [Related]
18. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
Liu J; Han M; Huang H
Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
[TBL] [Abstract][Full Text] [Related]
19. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
[TBL] [Abstract][Full Text] [Related]
20. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
